Does warfarin provide benefit in patients with progressive idiopathic pulmonary fibrosis?
Warfarin should not be used for the treatment of progressive idiopathic pulmonary fibrosis in patients without other indications for anticoagulation due to an increased risk of mortality.
This study did not show a benefit for warfarin in the treatment of patients with progressive IPF. Treatment with warfarin was associated with an increased risk of mortality in an IPF population who lacked other indications for anticoagulation.
Noth et al. (Sat,) studied this question.